APA (7th ed.) Citation

MT, M., AM, P., SH, K., TY, F., MR, D., CN, H., . . . MR, R. (2025). TLR5 Signaling Causes Dendritic Cell Dysfunction and Orchestrates Failure of Immune Checkpoint Therapy against Ovarian Cancer. Cancer immunology research, 13(5), 696. https://doi.org/10.1158/2326-6066.CIR-24-0513

Chicago Style (17th ed.) Citation

MT, McGinty, et al. "TLR5 Signaling Causes Dendritic Cell Dysfunction and Orchestrates Failure of Immune Checkpoint Therapy Against Ovarian Cancer." Cancer Immunology Research 13, no. 5 (2025): 696. https://doi.org/10.1158/2326-6066.CIR-24-0513.

MLA (9th ed.) Citation

MT, McGinty, et al. "TLR5 Signaling Causes Dendritic Cell Dysfunction and Orchestrates Failure of Immune Checkpoint Therapy Against Ovarian Cancer." Cancer Immunology Research, vol. 13, no. 5, 2025, p. 696, https://doi.org/10.1158/2326-6066.CIR-24-0513.